The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
The Role of Antibody Polyspecificity and Lipid Reactivity in Binding of Broadly Neutralizing Anti-HIV-1 Envelope Human Monoclonal Antibodies 2F5 and 4E10 to Glycoprotein 41 Membrane Proximal Envelope Epitopes
Open accessAbstract
Two neutralizing human mAbs, 2F5 and 4E10, that react with the HIV-1 envelope gp41 membrane proximal region are also polyspecific autoantibodies that bind to anionic phospholipids. To determine the autoantibody nature of these Abs, we have compared their reactivities with human anti-cardiolipin mAbs derived from a primary antiphospholipid syndrome patient. To define the role of lipid polyreactivity in binding of 2F5 and 4E10 mAbs to HIV-1 envelope membrane proximal epitopes, we determined the kinetics of binding of mAbs 2F5 and 4E10 to their nominal gp41 epitopes vs liposome-gp41 peptide conjugates. Both anti-HIV-1 mAbs 2F5 and 4E10 bound to cardiolipin with Kd values similar to those of autoimmune anti-cardiolipin Abs, IS4 and IS6. Binding kinetics studies revealed that mAb 2F5 and 4E10 binding to their respective gp41 peptide-lipid conjugates could best be defined by a two-step (encounter-docking) conformational change model. In contrast, binding of 2F5 and 4E10 mAbs to linear peptide epitopes followed a simple Langmuir model. A mouse mAb, 13H11, that cross-blocks mAb 2F5 binding to the gp41 epitope did not cross-react with lipids nor did it neutralize HIV-1 viruses. Taken together, these data demonstrate the similarity of 2F5 and 4E10 mAbs to known anti-cardiolipin Abs and support the model that mAb 2F5 and 4E10 binding to HIV-1 involves both viral lipid membrane and gp41 membrane proximal epitopes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunobiology: the immune system in health and disease
(1995) · Choice Reviews Online · doi:10.5860/choice.32-3876 · Cited by 4,110
Predominant Autoantibody Production by Early Human B Cell Precursors
Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E., & Nussenzweig, M. C. (2003) · Science · doi:10.1126/science.1086907 · Cited by 2,083
The antigenic structure of the HIV gp120 envelope glycoprotein
Wyatt, R., Kwong, P. D., Desjardins, E., Sweet, R. W., Robinson, J., Hendrickson, W. A., & Sodroski, J. G. (1998) · Nature · doi:10.1038/31514 · Cited by 1,203
Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes
Nemazee, D. A., & Bürki, K. (1989) · Nature · doi:10.1038/337562a0 · Cited by 1,016
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Rüker, F., & Katinger, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6642-6647.1993 · Cited by 1,004
Receptor editing: an approach by autoreactive B cells to escape tolerance.
Gay, D., Saunders, T., Camper, S., & Weigert, M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.999 · Cited by 920
Loder, B. F., Mutschler, B., Ray, R. J., Paige, C. J., Sideras, P., Torres, R., Lamers, M. C., & Carsetti, R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.1.75 · Cited by 863
(2011) · SpringerReference · doi:10.1007/springerreference_40291 · Cited by 829
Distribution and three-dimensional structure of AIDS virus envelope spikes
Zhu, P., Liu, J., Bess, J., Chertova, E., Lifson, J. D., Grisé, H., Ofek, G. A., Taylor, K. A., & Roux, K. H. (2006) · Nature · doi:10.1038/nature04817 · Cited by 780
Receptor editing in self-reactive bone marrow B cells.
Tiegs, S. L., Russell, D. M., & Nemazee, D. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.1009 · Cited by 766
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
Haynes, B. F., Fleming, J., St. Clair, E. W., Katinger, H., Stiegler, G., Kunert, R., Robinson, J., Scearce, R. M., Plonk, K., Staats, H. F., et al. (2005) · Science · doi:10.1126/science.1111781 · Cited by 744
Self-citationIdentification and characterization of circulating human transitional B cells
Sims, G. P., Ettinger, R., Shirota, Y., Yarboro, C. H., Illei, G. G., & Lipsky, P. E. (2005) · Blood · doi:10.1182/blood-2004-11-4284 · Cited by 604
Stiegler, G., Kunert, R., Purtscher, M., Wolbank, S., Voglauer, R., Steindl, F., & Katinger, H. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/08892220152741450 · Cited by 517
Trkola, A., Kuster, H., Rusert, P., Joos, B., Fischer, M., Leemann, C., Manrique, A., Huber, M., Rehr, M., Oxenius, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1244 · Cited by 502
Ofek, G., Tang, M., Sambor, A., Katinger, H., Mascola, J. R., Wyatt, R., & Kwong, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10724-10737.2004 · Cited by 490
Cardoso, R. M. F., Zwick, M. B., Stanfield, R. L., Kunert, R., Binley, J. M., Katinger, H., Burton, D. R., & Wilson, I. A. (2005) · Immunity · doi:10.1016/j.immuni.2004.12.011 · Cited by 449
Wyatt, R., Moore, J., Accola, M., Desjardin, E., Robinson, J., & Sodroski, J. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5723-5733.1995 · Cited by 417
Antibody regulation of B cell development
Meffre, E., Casellas, R., & Nussenzweig, M. C. (2000) · Nature Immunology · doi:10.1038/80816 · Cited by 283
Prevalence, Follow-Up and Clinical Significance of the Anticardiolipin Antibodies in Normal Subjects
Vila, P., Hernández, M. C., López-Fernández, M. F., & Batlle, J. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648840 · Cited by 280
Zwick, M. B., Jensen, R., Church, S., Wang, M., Stiegler, G., Kunert, R., Katinger, H., & Burton, D. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1252-1261.2005 · Cited by 278
Hunt, J. E., McNeil, H. P., Morgan, G. J., Crameri, R. M., & Krilis, S. A. (1992) · Lupus · doi:10.1177/096120339200100204 · Cited by 257
Earl, P. L., Broder, C. C., Long, D., Lee, S. A., Peterson, J., Chakrabarti, S., Doms, R. W., & Moss, B. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.3015-3026.1994 · Cited by 215
Gao, F., Weaver, E. A., Lu, Z., Li, Y., Liao, H.-X., Ma, B., Alam, S. M., Scearce, R. M., Sutherland, L. L., Yu, J.-S., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1154-1163.2005 · Cited by 200
Self-citationTsutsumi, A., Matsuura, E., Ichikawa, K., Fujisaku, A., Mukai, M., Kobayashi, S., & Koike, T. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390905 · Cited by 194
Liao, H.-X., Sutherland, L. L., Xia, S.-M., Brock, M. E., Scearce, R. M., Vanleeuwen, S., Alam, S. M., McAdams, M., Weaver, E. A., Camacho, Z. T., et al. (2006) · Virology · doi:10.1016/j.virol.2006.04.043 · Cited by 184
Self-citationAntibody polyspecificity and neutralization of HIV-1: A hypothesis
Haynes, B. F., Moody, M. A., Verkoczy, L., Kelsoe, G., & Alam, S. M. (2006) · Human Antibodies · doi:10.3233/hab-2005-143-402 · Cited by 163
Self-citationZwick, M. B., Wang, M., Poignard, P., Stiegler, G., Katinger, H., Burton, D. R., & Parren, P. W. H. I. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12198-12208.2001 · Cited by 160
Meffre, E., Milili, M., Blanco-Betancourt, C., Antunes, H., Nussenzweig, M. C., & Schiff, C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13051 · Cited by 152
Bures, R., Gaitan, A., Zhu, T., Graziosi, C., McGrath, K. M., Tartaglia, J., Caudrelier, P., Habib, R. E., Klein, M. C. A., Lazzarin, A., et al. (2000) · AIDS Research and Human Retroviruses · doi:10.1089/088922200750054756 · Cited by 147
Brunel, F. M., Zwick, M. B., Cardoso, R. M. F., Nelson, J. D., Wilson, I. A., Burton, D. R., & Dawson, P. E. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1680-1687.2006 · Cited by 137
Barbato, G., Bianchi, E., Ingallinella, P., Hurni, W. H., Miller, M. D., Ciliberto, G., Cortese, R., Bazzo, R., Shiver, J. W., & Pessi, A. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00611-9 · Cited by 136
MacKenzie, C. R., Hirama, T., Deng, S.-J., Bundle, D. R., Narang, S. A., & Young, N. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1527 · Cited by 134
Krishnan, M. R., Jou, N. T., & Marion, T. N. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.6.2430 · Cited by 114
McGaughey, G. B., Citron, M. P., Danzeisen, R. C., Freidinger, R. M., Garsky, V. M., Hurni, W. M., Joyce, J. G., Liang, X., Miller, M. D., Shiver, J. W., et al. (2003) · Biochemistry · doi:10.1021/bi026952u · Cited by 103
Experimental Design for Analysis of Complex Kinetics Using Surface Plasmon Resonance
Lipschultz, C. A., Li, Y., & Smith‐Gill, S. J. (2000) · Methods · doi:10.1006/meth.1999.0924 · Cited by 93
Solid-Phase Proteoliposomes Containing Human Immunodeficiency Virus Envelope Glycoproteins
Grundner, C., Mirzabekov, T. A., Sodroski, J., & Wyatt, R. T. (2002) · Journal of Virology · doi:10.1128/jvi.76.7.3511-3521.2002 · Cited by 92
Zhu, M., Olee, T., Le, D. T., Roubey, R. A. S., Hahn, B. H., Woods, V. L., & Chen, P. P. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01292.x · Cited by 79
Self-citationMcNally, T., Mackie, I. J., Machin, S. J., & Isenberg, D. A. (1995) · Lara D. Veeken · doi:10.1093/rheumatology/34.11.1031 · Cited by 74
Joos, B., Trkola, A., Kuster, H., Aceto, L., Fischer, M., Stiegler, G. M., Armbruster, C., Vcelar, B. A., Katinger, H. W. D., & Günthard, H. F. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1773-1779.2006 · Cited by 64
Ways, J. P., & Parham, P. (1983) · Biochemical Journal · doi:10.1042/bj2160423 · Cited by 58
Autoantibodies, lupus and the science of sabotage
Rahman, A. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh354 · Cited by 55
Sánchez-Martínez, S., Lorizate, M., Katinger, H. W. D., Kunert, R., Basáñez, G., & Nieva, J. L. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.067 · Cited by 49
Giles, I., Haley, J., Nagl, S., Isenberg, D. A., Latchman, D. S., & Rahman, A. (2003) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2003.49994 · Cited by 44
Chukwuocha, R. U., Zhu, M., Cho, C. S., Visvanathan, S., Hwang, K. K., Rahman, A., & Chen, P. P. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00115-3 · Cited by 29
Self-citationBoffey, J., Nicholl, D., Wagner, E. R., Townson, K. H., Goodyear, C. S., Furukawa, K., Furukawa, K., Conner, J., & Willison, H. J. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.04.002 · Cited by 28
The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin
Giles, I., Lambrianides, N., Latchman, D. S., Chen, P. P., Chukwuocha, R. U., Isenberg, D. A., & Rahman, A. (2004) · Arthritis Research & Therapy · doi:10.1186/ar1449 · Cited by 26
Self-citationThe molecular basis of antiphospholipid syndrome
Gharavi, A. E., Wilson, W., & Pierangeli, S. S. (2003) · Lupus · doi:10.1191/0961203303lu448rr · Cited by 21
Janeway, C. A., Travers, P. M., Walport, M. J., et al. (2001) · Cited by 11
Cited by
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Liao, H.-X., Lynch, R., Zhou, T., Gao, F., Alam, S. M., Boyd, S. D., Fire, A. Z., Roskin, K. M., Schramm, C. A., Zhang, Z., et al. (2013) · Nature · doi:10.1038/nature12053 · Cited by 988
Self-citationThe immune response during acute HIV-1 infection: clues for vaccine development
McMichael, A. J., Borrow, P., Tomaras, G. D., Goonetilleke, N., & Haynes, B. F. (2010) · Nature Reviews Immunology · doi:10.1038/nri2674 · Cited by 871
Self-citationHIV‐1 neutralizing antibodies: understanding nature's pathways
Mascola, J. R., & Haynes, B. F. (2013) · Immunological Reviews · doi:10.1111/imr.12075 · Cited by 475
Self-citationAntibodies in HIV-1 Vaccine Development and Therapy
Klein, F., Mouquet, H., Dosenovic, P., Scheid, J. F., Scharf, L., & Nussenzweig, M. C. (2013) · Science · doi:10.1126/science.1241144 · Cited by 457
Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
Kwong, P. D., & Mascola, J. R. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.012 · Cited by 455
Metadata
- Authors
- Alam, S. M., McAdams, M., Boren, D., Rak, M., Scearce, R. M., Gao, F., Camacho, Z. T., Gewirth, D., Kelsoe, G., Chen, P., & Haynes, B. F.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04-01
- Volume
- 178
- Issue
- 7
- Pages
- 4424-4435
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2095910488
- Cited by
- 260
- References
- 48
- FWCI
- 9.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.